As outlined above, C3a and C5a have neuroprotective/regenerative roles, and whereas CR2-fH treatment significantly inhibited C5a generation in the ipsilateral brain for up to 3 days after stroke, C5a levels were still significantly higher than in brains from CR2-Crry-treated mice. This evidence concerns the gene C3 and stroke disorder.